Published on February 22, 2017, Bayer AG Financial Statements 2015 Bayer Annual Report 2017 The integrated Bayer Annual Report 2017 is available in a print version and in an aug-mented online version (Annual Report 2017 - Augmented . Bayer Annual Report 2005 - Free download as PDF File (.pdf), Text File (.txt) or read online for free. The 2016 Monsanto Annual Report, which was released today, is now available online by visiting the company's website at www.monsanto.com and clicking on the Investor Information tab. 57 th Annual Report (April 2014 to March 2015) Download (pdf, English, 3 MB) 56 th Annual Report (April 2013 to March 2014) Magazine; Access to innovative health solutions. The organisation's status is listed as "Active". +8.9% EBITDA before special items 11.2 billion -2.5% Core earnings per share 6.51 +1.9% Downloads and Services MILTON BAYER LIMITED was founded on 2014-06-12 and has its registered office in Northampton. The data for the years prior to 2017 were taken from older Bayer annual reports. Published on February 27, 2019, Bayer AG Financial Statements 2017 Bayer's transformation into a pure Life Science company has >JINDNO@IOGT =@@I >>JHK D @ $O ? 57th Annual Report (April 2014 to March 2015) - Download PDF (4.68 MB) As it contains supplementary information such as notes to the consolidated financial statements of Bayer Group, it is considered an Augmented Version. The Annual Report combines our financial reporting and our nonfinancial statement, which contains all material sustainability information required by commercial law. Request Information View 2021 Sustainability Report Bayer AG - AnnualReports.com 10,000+ Employees Based in Leverkusen, Germany Most Recent Annual Report MOST RECENT 2021 Annual Report View PDF Bayer AG does not currently have any hardcopy reports on AnnualReports.com. 2015 Annual Report. Connecting: I proactively reach out to stakeholders across the globe to understand their needs and build relationships. Chairman and CEO Letter and Amgen Inc. 2015 Annual Report 1.3 MB. Bayer AG Ad-hoc Mitteilungen 2010. The Bayer brand stands for trust, reliability and quality throughout the world. audits/screenings) for compliance within the companys sphere of influence, Undertake awareness-raising, training and other types of capacity building with suppliers and other business partners. Bayer UNGC Progress Report: http://www.geschaeftsbericht2015.bayer.de/serviceseiten/downloads/files/ungc_blueprint_report_bayer_gb15.pdf , p.7 http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf, p.81ff. Bayer AG Ad-hoc Announcement October 31, 2010. 2019 Annual Report and Proxy Statement . This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group. Detailed Insights and Projections from This Past Year, Financial Key Figures 2021 as Excel files, Financial Key Figures 2020 as Excel files, Data Privacy Information For Specific Processing Activities, Stem cells - The new age of medical research, Moving Non-Communicable Diseases Care Forward, Inspiring Creativity and Improving Health, EU Verification Logo against Counterfeit Drugs, New Safety Features for Prescription Medicine in Europe, The Crop Science Sustainability Progress Report, Reducing Crop Protections Environmental Impact, Environmental Impact Reduction Reporting Results, Sustainable Agriculture in practice: Bayer ForwardFarming, Conserving Natural Resources in Agriculture, Position on Deforestation and Forest Degradation, Raising the Bar on Crop Protection Safety Standards, Transfers of Values to Healthcare Professionals, Collaboration with Healthcare Professionals, Sustainability & Socially Responsible Investing, Duties and Activities of the Board of Management, International Trainee Program for Financial Management, International Future Leadership Program - Engineers, Global Supply Chain Management Trainee Program, International Procurement Management Trainee Program, International Future Leadership Program - Pharmaceuticals and Consumer Health Product Supply, Integrated Annual Report 2018 - Download PDF (3.88 MB), Annual Report 2017 - Download PDF (10.15 MB), Annual Report 2016 - Download PDF (9.19 MB), Annual Report 2015 - Download PDF (12.02 MB), Annual Report 2014 - Download PDF (7.98 MB), Annual Report 2013 - Download PDF (7.23 MB), Annual Report 2012 - Download PDF (6.33 MB), Annual Report 2011 - Download PDF (8.39 MB), Annual Report 2010 - Download PDF (6.17 MB). for Sustainability (TfS, co-founded bei Bayer) initiative and the Pharmaceutical Supply Chain Initiative (PSCI). 2020 Annual Report and Proxy Statement. Bayers leadership in agriculture provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy. Share via email. Published on February 25, 2016, Bayer AG Financial Statements 2014 For the development and establishment of a sustainability standard for our supply base we are working with both the Together @HJI- strates the strength of our company and the commitment of our employees. * After spin-off, Covestro is no longer included from 2016 on. Board establishes, where permissible, a committee or assigns an individual board member with responsibility for corporate sustainability. Chairman and CEO Letter and Amgen Inc. 2014 Annual Report 2.5 MB. Participation and leadership by employers organizations (international and national) to jointly address challenges related to labour standards in the countries of operation, possibly in a tripartite approach (business trade union government). Published on February 28, 2011. 2. Share to Tumblr. Aktienkurse 2014. 0.5 billion // Pharmaceuticals with . Bayer Annual Report Augmented Version 2016, p. 56ff. Bayer Annual Report 2015 web file MSMS (Making Science Make Sense) program provides school students with an insight into everyday natural science phenomena with the help of all kinds of fascinating experiments. Read more about our economic, ecological and social challenges and opportunities. Since 2018 the Annual Report is available only as an online version. As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. Message Stock Prices 2014. Our aim is to elucidate the interactions between financial, ecological and societal factors and underline their influence on our companys long-term success. Aktienkurse 2014. Bayer AG is the parent corporation of the Bayer Group. Published on March 1, 2022, Bayer AG Financial Statements 2020 . Bayer is an innovation company with a more than 150-year history. The financial statements of Bayer AG were prepared according to the requirements of the German. Kein Text mit angegebener Global Websites Bayer Holding; Other Links . The following files are available for download. whistleblower mechanisms) for reporting concerns or seeking advice regarding environmental impacts, Bayer UNGC Progress Report p.5-6: http://www.geschaeftsbericht2015.bayer.de/serviceseiten/downloads/files/ungc_blueprint_report_bayer_gb15.pdf, Reference to relevant international conventions and other international instruments (e.g. Annual Report Bayer Annual Report 2019 Five-Year Summary2 Five-Year Summary million 2015 2016 2017 20182019 Bayer Group Sales 46,085 34,943 35,015 36,742 43,545 EBITDA19,573 8,801 8,563 9,695 9,554 EBITDA before special items110,256 9,318 9,288 8,96911,503 EBITDA margin before special items122.3% 26.7% 26.5% 24.4%26.4% Overview; Profile and Organization. Our scientific successes are intended to help improve peoples lives. Share to Twitter. 2011 Annual Report. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact. 2013 Annual Report. Our scientific successes are intended to help improve peoples lives. Bayer Annual Report 2018, p.31 (resource efficiency company goals) Any relevant policies, procedures, and activities that the company plans to undertake by its next COP to fulfill this criterion, including goals, timelines, metrics, and responsible staff Anti-Corruption The population is constantly growing and its age is increasing. For me, it was the rst full year as ceo of Bayer. At a Glance; . 2015_Annual_Report__augmented_version.pdf, This COP qualifies for the Global Compact Advanced level, Includes a CEO statement of continued support for the UN Global Compact and its ten principles, Description of actions or relevant policies related to Human Rights, Description of actions or relevant policies related to Labour, Description of actions or relevant policies related to Environment, Description of actions or relevant policies related to Anti-Corruption, Meets all criteria for the GC Advanced level. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Learn more about Bayer and the opportunities available. Learn more about Bayer and the opportunities available. With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. Publicly advocate the importance of action in relation to one or more UN goals/issues, Commit company leaders to participate in key summits, conferences, and other important public policy interactions in relation to one or more UN goals/issues. CEO leads executive management team in development of corporate sustainability strategy, defining goals and overseeing implementation, CEO publicly delivers explicit statements and demonstrates personal leadership on sustainability and commitment to the UN Global Compact, CEO promotes initiatives to enhance sustainability of the companys sector and leads development of industry standards, Make sustainability criteria and UN Global Compact principles part of goals and incentive schemes for CEO and executive management team, Publicly recognize responsibility for the companys impacts on internal and external stakeholders, Define sustainability strategies, goals and policies in consultation with key stakeholders, Consult stakeholders in dealing with implementation dilemmas and challenges and invite them to take active part in reviewing performance, Establish channels to engage with employees and other stakeholders to hear their ideas and address their concerns. Bayer AG Ad-hoc Announcement October 31, 2010. View bayer-annual-report-2018.pdf from AA 1Annual Report 2018 2 Bayer Annual Report 2018 Five-Year Summary Five-Year Summary 2014 2015 2016 2017 2018 Bayer Group ( Bayer-Geschftsbericht 2018 A Zusammengefasster Lagebericht 1 Fehler! Any relevant policies, procedures, and activities that the company plans to undertake by its next COP to fulfill this criterion, including goals, timelines, metrics, and responsible staff, Analyze each segment of the value chain carefully, both upstream and downstream, when mapping risks, opportunities and impacts, Communicate policies and expectations to suppliers and other relevant business partners, Implement monitoring and assurance mechanisms (e.g. Investing in a stronger future - for our shareholders, and for the world. Bayer is an innovation company with a more than 150-year history. Commercial Code and Stock Corporation Act. Share to Pinterest. At a Glance; . Digital (health): Dr Michael Devoy; Patient safety; . 03.26.2015. Looking for a job in an innovative company? Annual Reports Bayer AG Financial Statements Compensation Reports Shareholder Information Debt Sustainable Investing Corporate Governance Document Download Tool Contact Us Bayer AG Financial Statements On this page you find the financial statements of Bayer AG. 2010 Annual Report and Proxy Statement. Share to Reddit. Learn more about Bayer and the opportunities available. One of the key objectives of our sustainability strategy is to balance economic growth with ecological and corporate social responsibility. Bayer Annual Report Augmented Version 2015, p. 79ff (Sustainability Management and Governance), see also UNGC Progress Report, p.2-3. About Leadership . Bayer UNGC Progress Report: http://www.geschaeftsbericht2015.bayer.de/serviceseiten/downloads/files/ungc_blueprint_report_bayer_gb15.pdf , p.9 http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf, p.81ff. For more information, go to www.bayer.com . Financial Key Figures 2021 as Excel files, Financial Key Figures 2020 as Excel files, Data Privacy Information For Specific Processing Activities, Stem cells - The new age of medical research, Moving Non-Communicable Diseases Care Forward, Inspiring Creativity and Improving Health, EU Verification Logo against Counterfeit Drugs, New Safety Features for Prescription Medicine in Europe, The Crop Science Sustainability Progress Report, Reducing Crop Protections Environmental Impact, Environmental Impact Reduction Reporting Results, Sustainable Agriculture in practice: Bayer ForwardFarming, Conserving Natural Resources in Agriculture, Position on Deforestation and Forest Degradation, Raising the Bar on Crop Protection Safety Standards, Transfers of Values to Healthcare Professionals, Collaboration with Healthcare Professionals, Sustainability & Socially Responsible Investing, Duties and Activities of the Board of Management, International Trainee Program for Financial Management, International Future Leadership Program - Engineers, Global Supply Chain Management Trainee Program, International Procurement Management Trainee Program, International Future Leadership Program - Pharmaceuticals and Consumer Health Product Supply, Bayer AG Financial Statements 2021 (PDF, 459 KB). Investing in a stronger future - for our shareholders, and for the world. Cross-Linking of Alpha 2-Plasmin Inhibitor to Fibrin by Fibrin- Stabilizing Factor; United States Patent (19) 11 Patent Number: 6,019,993 Bal (45) Date of Patent: Feb; With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. Company Name : MILTON BAYER LIMITED : Board (or committee), where permissible, approves formal reporting on corporate sustainability (Communication on Progress). Annual turnover is less than 6.5 million The balance sheet total is less than 3.26 million Employs less than 50 employees Key Data. You can find further information and in-depth insights into both our sustainability strategy and our sustainability performance in the Sustainability Report. Click the button below to request a report when hardcopies become available. Our Annual Integrated Report explains how Solvay delivered outstanding financial results and made significant progress toward achieving sustainability goals, in a challenging environment marked by inflation, logistical issues and increasingly strict environmental regulations. The Bayer Group annual reports can be foundin chapter"Annual Reports". Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Published on February 27, 2020, Bayer AG Financial Statements 2018 Looking for a job in an innovative company? Since the IPO of Covestro in October 2015, we have been aiming to sell our shares step by step and to achieve full sepa - ration from Covestro in the medium term. Learn more about it here. The online version contains the notes to the consolidated financial statements of the Bayer Group, along with additional information. 2014 Annual Report. Your message has been sent. Published on February 25, 2021, Bayer AG Financial Statements 2019 Published on February 28, 2012, Bayer AG Financial Statements 2010 In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Our scientific successes are intended to help improve peoples lives. 2012 Annual Report. Bayer AG Financial Statements 2021 Rio Declaration on Environment and Development), Reflection on the relevance of environmental stewardship for the company, Written company policy on environmental stewardship, Inclusion of minimum environmental standards in contracts with suppliers and other relevant business partners, Specific commitments and goals for specified years. Read more about our economic, ecological and social challenges and opportunities. US$9.9 billion distributed in supplier payments, employee wages and benefits, shareholder returns . Last year . As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. Bayers leadership in agriculture provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy. Investors. Bayer Aktiengesellschaft is primarely in the business of pharmaceutical preparations. The digital magazine offers interesting glimpses of Bayer's global scope as a life-science company. With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group. We will increase the entire annual r &d budget of CropScience by some 20 percent within this time span, to more Bayer AG Ad-hoc Mitteilungen 2010. Read more about our economic, ecological and social challenges and opportunities. What continues to . The Annual Report combines our financial reporting and our nonfinancial statement, which contains all material sustainability information required by commercial law. The financial statements of Bayer AG, which is the parent company of the Bayer Group, were prepared according to the requirements of the German Commercial Code and Stock Corporation Act. Integrated Annual Reports 2015. . The consolidated financial statements of the Bayer Group were prepared according to the German Commercial Code and the International Financial Reporting Standards (IFRS). Sorry, you need to enable JavaScript to visit this website. Cross-Linking of Alpha 2-Plasmin Inhibitor to Fibrin by Fibrin- Stabilizing Factor, United States Patent (19) 11 Patent Number: 6,019,993 Bal (45) Date of Patent: Feb, Safety and Efficacy of Prothrombin Complex Concentrate As First-Line, A Study on Ulinastatin in Preventing Post ERCP Pancreatitis, Antiproteases in Preventing Post-ERCP Acute Pancreatitis, Alternatives and Adjuncts to Blood Transfusion, Prothrombin Complex Concentrates: a Brief Review, Pharmacological Interventions for Acute Pancreatitis (Review), Clinical Review: Prothrombin Complex Concentrates - Evaluation of Safety and Thrombogenicity, Stability of an Autologous Platelet Clot in the Pericardial Sac: an Experimental and Clinical Study, Antifibrinolytic Therapy in Cardiac Surgery, Questions and Answers on the Review of Antifibrinolytic Medicines, Aprotinin Bovine, Recombinant, Expressed in Nicotiana (Tobacco), Improved Tissue Glue Prepared by Using Cryoprecipitate, A Compendium of Transfusion Practice Guidelines Edition 4.0 January 2021, Comparative Analysis of Prothrombin Complex Concentrate and Fresh, Tenncare Attestation List September 1, 2021, Comparative Effectiveness of In-Hospital Use of Recombinant, Syk Inhibits the Activity of Protein Kinase a By, Financial Statements Bayer Annual Report 2017 Bayer Group Consolidated Income Statements, List Item PDCO Monthly Report of Opinions on Paediatric Investigation, Effect of Ulinastatin on Post-Operative Blood Loss and Allogeneic, Bayer Aktiengesellschaft Bayer Capital Corporation B.V, BAYER AKTIENGESELLSCHAFT (Incorporated in the Federal Republic of Germany) As Issuer EUR 1,300,000,000 Subordinated Resettable Fixed Rate Notes Due 2075, Discrimination Between Fibrin and Fibrinogen by a Monoclonal, Debt Issuance Programme Prospectus Dated March 24, 2017, Critical Quality Attributes Pertaining to Immunogenicity: a Preponderance of Evidence Approach to Control Strategies, Aprotinin Inhibits SARS-Cov-2 Replication, In-Silico Analysis of Potential Interaction of Drugs and the SARS-Cov-2 Spike Protein, Injectables and Depots to Prolong Drug Action of Proteins and Peptides, Adult Inpatient/Emergency Department Procoagulant Clinical Practice Guideline (CPG) Cover Sheet, PRAC Draft Agenda of Meeting 28 September, Aprotinin a Popular Serine Proteases Inhibitors, TRASYLOL (Aprotinin Injection) 01298181 12/03, Bayer Annual Report 2015 Consolidated Financial Statements Bayer Group Consolidated Income Statements, Therapeutic Application of Alpha-1-Antitrypsin in COVID-19, HEPATIC ARTERIAL LESIONS Reported Manifestations, INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri, Antifibrinolytics for Pediatric CPB Which Drug, How Much and When? (Sustainability Management) Any relevant policies, procedures, and activities that the company plans to undertake by its next COP to fulfill this criterion, including goals, timelines, metrics, and responsible staff Criterion 2: The COP describes value chain implementation INDEPENDENT AUDITORS' REPORT 331 INDEPENDENT ASSURANCE REPORT 333 03 FURTHER INFORMATION 336 Financial Calendar Masthead, Disclaimer ABOUT THE INTEGRATED REPORT This year's Annual Report combinesourfinancialand our sustainability reporting forthefirsttime.Onpage 28-29youcanfindfurther .